Nigel Bourne

4.8k total citations
110 papers, 3.8k citations indexed

About

Nigel Bourne is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nigel Bourne has authored 110 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 31 papers in Infectious Diseases and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nigel Bourne's work include Herpesvirus Infections and Treatments (46 papers), Mosquito-borne diseases and control (29 papers) and Viral Infections and Vectors (26 papers). Nigel Bourne is often cited by papers focused on Herpesvirus Infections and Treatments (46 papers), Mosquito-borne diseases and control (29 papers) and Viral Infections and Vectors (26 papers). Nigel Bourne collaborates with scholars based in United States, United Kingdom and Germany. Nigel Bourne's co-authors include Gregg N. Milligan, Lawrence R. Stanberry, David I. Bernstein, Alan D.T. Barrett, Mark R. Schleiss, Richard B. Pyles, Peter W. Mason, Fernando Bravo, Ronald L. Veselenak and Vanessa V. Sarathy and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Nigel Bourne

108 papers receiving 3.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nigel Bourne 1.7k 1.2k 1.0k 665 628 110 3.8k
Frédéric Tangy 1.9k 1.1× 2.1k 1.7× 1.1k 1.1× 1.4k 2.1× 1.5k 2.4× 157 5.4k
Nathalie Garçon 1.7k 1.0× 1.3k 1.1× 991 1.0× 2.8k 4.3× 1.7k 2.6× 67 5.3k
H. Snippe 1.6k 0.9× 775 0.6× 549 0.5× 1.1k 1.7× 1.1k 1.7× 156 3.6k
Ralf Altmeyer 778 0.4× 2.0k 1.7× 524 0.5× 749 1.1× 934 1.5× 58 3.8k
José Mauro Peralta 1.1k 0.6× 1.5k 1.3× 961 0.9× 307 0.5× 711 1.1× 138 4.0k
Brian C. Keller 643 0.4× 1.1k 0.9× 605 0.6× 723 1.1× 1.5k 2.3× 48 3.4k
R. V. Blanden 1.4k 0.8× 1.2k 1.0× 761 0.7× 3.3k 5.0× 956 1.5× 144 5.8k
Hugh J. Field 3.9k 2.2× 590 0.5× 312 0.3× 1.1k 1.6× 663 1.1× 133 4.9k
Sylvie Bertholet 1.8k 1.0× 1.3k 1.1× 1.4k 1.4× 2.5k 3.8× 1.5k 2.4× 60 5.0k
Qinxue Hu 764 0.4× 1.3k 1.1× 366 0.4× 1.0k 1.6× 984 1.6× 101 3.5k

Countries citing papers authored by Nigel Bourne

Since Specialization
Citations

This map shows the geographic impact of Nigel Bourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Bourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Bourne more than expected).

Fields of papers citing papers by Nigel Bourne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Bourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Bourne. The network helps show where Nigel Bourne may publish in the future.

Co-authorship network of co-authors of Nigel Bourne

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Bourne. A scholar is included among the top collaborators of Nigel Bourne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Bourne. Nigel Bourne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ostrowsky, Julie, Leah C. Katzelnick, Nigel Bourne, et al.. (2025). Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development. The Lancet Infectious Diseases. 25(7). e402–e415. 5 indexed citations
2.
Escaffre, Olivier, Terry L. Juelich, Jennifer K. Smith, et al.. (2023). The Susceptibility of BALB/c Mice to a Mouse-Adapted Ebola Virus Intravaginal Infection. Viruses. 15(7). 1590–1590.
3.
Files, Megan, Craig Schindewolf, Alan D.T. Barrett, et al.. (2022). Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development. npj Vaccines. 7(1). 38–38. 48 indexed citations
4.
Bourne, Nigel, et al.. (2019). Development of an anti-guinea pig CD4 monoclonal antibody for depletion of CD4+ T cells in vivo. Journal of Immunological Methods. 474. 112654–112654. 3 indexed citations
5.
Veselenak, Ronald L., Gregg N. Milligan, Aaron L. Miller, Richard B. Pyles, & Nigel Bourne. (2018). Transcriptional Analysis of the Guinea Pig Mucosal Immune Response to Intravaginal Infection with Herpes Simplex Virus Type 2. Virology. 518. 349–357. 5 indexed citations
7.
Winkelmann, E., Douglas G. Widman, Alison J. Johnson, et al.. (2014). Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses. Virology. 450-451. 278–289. 20 indexed citations
8.
Vincent, Kathleen L., Gracie Vargas, Nigel Bourne, et al.. (2013). Image-Based Noninvasive Evaluation of Colorectal Mucosal Injury in Sheep After Topical Application of Microbicides. Sexually Transmitted Diseases. 40(11). 854–859. 8 indexed citations
9.
Shavkunov, Alexander S., et al.. (2012). Bioluminescence Methodology for the Detection of Protein–Protein Interactions Within the Voltage-Gated Sodium Channel Macromolecular Complex. Assay and Drug Development Technologies. 10(2). 148–160. 35 indexed citations
10.
Bourne, Nigel, et al.. (2005). Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system. Antiviral Research. 67(2). 76–82. 34 indexed citations
11.
Bourne, Nigel, et al.. (2003). Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. Clinical Microbiology and Infection. 9(8). 816–822. 21 indexed citations
12.
Burger, Richard M., et al.. (2001). Pre-clinical characterization of CTC-96 in a non-spermicidal topical virucide. AIDS. 15. S40–S40. 1 indexed citations
13.
Schleiss, Mark R., Nigel Bourne, Nancy J. Jensen, Fernando Bravo, & David I. Bernstein. (2000). Immunogenicity Evaluation of DNA Vaccines That Target Guinea Pig Cytomegalovirus Proteins Glycoprotein B and UL83. Viral Immunology. 13(2). 155–167. 27 indexed citations
14.
Bourne, Nigel, et al.. (2000). Immune Protection against HSV-2 in B-Cell-Deficient Mice. Virology. 270(2). 454–463. 53 indexed citations
15.
Bourne, Nigel, Fernando Bravo, & David I. Bernstein. (2000). Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals. Antiviral Research. 47(2). 103–109. 15 indexed citations
17.
Yoshikawa, Tetsushi, et al.. (1996). The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region.. The Journal of Experimental Medicine. 184(2). 659–664. 44 indexed citations
18.
Krause, Philip R., Lawrence R. Stanberry, Nigel Bourne, et al.. (1995). Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs.. The Journal of Experimental Medicine. 181(1). 297–306. 72 indexed citations
19.
Stanberry, Lawrence R., Nigel Bourne, Fernando Bravo, & David I. Bernstein. (1992). Capsaicin‐sensitive peptidergic neurons are involved in the zosteriform spread of herpes simplex virus infection. Journal of Medical Virology. 38(2). 142–146. 8 indexed citations
20.
Keevil, C. W., et al.. (1983). Synthesis of a fructosyltransferase by Streptococcus sanguis. FEMS Microbiology Letters. 20(2). 155–157. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026